HOME >> BIOLOGY >> NEWS
The role of phytochromes in bacteria revealed

The phytochromes are photosensitive substances which play an essential role in the various phases of plant development and growth. As photoreceptors they act as sensors that convey information to the plant about changes in ambient light. The two existing forms -active and inactive- can switch one to the other in response to such changes. Under red light they become active and trigger off a cascade of biochemical, in the plant cells to induce processes such as germination, flowering or stem elongation. Although it is well established that phytochromes function like light switches, the chain of biochemical reactions triggered when they are activated are still not well understood. Phytochromes were discovered in bacteria five years ago. However, their role even in these simple organisms has remained difficult to fathom. This has now been partially clarified by researchers from the IRD (Institut de Recherche pour le Dveloppement) and the CEA in conjunction with the CNRS. Their revelatory work has just been published in Nature. The study of bacteriophytochromes might give useful insights into the functional mechanisms of their counterparts in plants.

A research team jointly involving the IRD, the CEA and the CNRS has very recently found phytochromes in a strain of nitrogen-fixing bacterium, Bradyrhizobium (1), symbiont on certain tropical leguminous plants (the Aeschynomene). Techniques of molecular biology, biophysics and biochemistry revealed that the newly-discovered phytochrome has an essential role as regulator of the bacteriums photosystem synthesis. An identical function was shown in the photosynthetic bacterium Rhodopseudomonas palustris, phylogenetically very close to Bradyrhizobium (2).

The researchers experimented by subjecting Bradyrhizobium cells to different wavelengths of light, from the red to the infrared. It appeared that the bacterial photosynthetic apparatus was synthesized in its complete form only when the phytochrome was in its active
'"/>

Contact: Marie Lise Sabrie
sabrie@paris.ird.fr
33-01-48-03-75-36
Institut de Recherche Pour le Dveloppement
13-May-2002


Page: 1 2 3

Related biology news :

1. Researchers find color sensitive atomic switch in bacteria
2. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
3. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
4. Scientists discover potential new way to control drug-resistant bacteria
5. 22nd amino acid synthesized and added to genetic code of e. coli bacteria
6. Missing genes may help explain why plague bacteria are so deadly
7. Complex cells likely arose from combination of bacterial and extreme-microbe genomes
8. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
9. UC Irvine scientists to develop vaccine to combat bioterrorism threat from deadly bacteria
10. UV light, coatings reduce bacterial adhesion up to 50 percent
11. PCB breakdown in rivers depends on sediment-specific bacteria, find Carnegie Mellon U. scientists

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The role phytochromes bacteria revealed

(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ... Competitive Profiles - NEC" report to their offering. ... will continue to supply a range of IT security ... company focus on the development of a Big Data ... in the Asia-Pacific region is ...
(Date:4/8/2015)... , April 8, 2015  Infinisource, a ... and services, and Morpho, a leading supplier of ... to produce the market,s most advanced biometrically-enabled time ... iSolved NXG time clock is setting a bold, ... labor data for the small and mid-size employer. ...
(Date:4/2/2015)... 2, 2015 In the ... far outperforms the strongest competitors, showing outstanding performance ... the system is capable of a throughput of ... up to be ten times faster than most ... performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
(Date:4/16/2015)... (PRWEB) April 16, 2015 Regis Technologies ... American Association for Cancer Research (AACR) annual meeting. Regis ... Convention Center, starting Saturday, April 18, in Philadelphia and ... claim to title of the oldest and largest organization ... fellowships and grants, and partners with survivors to promote ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 ... at Charlotte (UNC Charlotte) spin-out company, announced today ... Cooper, Ph.D., M.D., as Chief Operating Officer (COO). ... of experience in developing clinical diagnostic and biotechnology ... infectious disease. , Cooper’s extensive career transcends the ...
(Date:4/16/2015)... 16, 2015  In recognition of World Hemophilia Day, ... groups to illuminate more than 15 prominent landmarks red throughout ... Boston,s Zakim Bridge and Prudential Tower, ... Mercedes-Benz Superdome and Denver,s ... of April 17, and coincide with hemophilia community events in ...
(Date:4/16/2015)... April 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... U.S. joint venture with G-treeBNT (ReGenTree LLC) has ... clinical trial for the orphan disorder, neurotrophic keratopathy ... dry eye syndrome (DES) in the U.S.  Both ... RGN-259/GBT201, this year.  Each of these eye disorders ...
Breaking Biology Technology:Regis Technologies Joins American Association for Cancer Research Annual Meeting 2OncoTAb Names Dr. David L. Cooper as COO 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 3Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5
Cached News: